AERIUS desloratadine 5mg tablet

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

desloratadine, Quantity: 5 mg

Available from:

Bayer Australia Ltd

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: Carnauba Wax; white beeswax; microcrystalline cellulose; maize starch; calcium hydrogen phosphate dihydrate; purified talc; hypromellose; macrogol 400; titanium dioxide; lactose monohydrate; indigo carmine

Administration route:

Oral

Units in package:

2,3,5,7,10,14,15,20,25,28,30,42,45,50,60, 1 tablet (Sample Pack)

Prescription type:

(S2) Pharmacy Medicine

Therapeutic indications:

The rapid relief of symptoms associated with seasonal allergic rhinitis. The nasal symptoms of allergic rhinits include rhinorrhoea, sneezing and nasal itching. Allergic rhinitis is also associated with non-nasal symptoms such as ocular itching, tearing and itching of the eyes or palate., The relief of symptoms associated with perennial allergic rhinitis., The symptomatic relief of itching and reduction in the size and number of hives associated with chronic idiopathic urticaria.

Product summary:

Visual Identification: Light blue round embossed film-coated tablets.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2003-05-28